Sunday, September 20, 2020
News
NEWS HOME
»
PRESS RELEASES

Tanner Pharma Group Announces LEUKINE EMERGENCY ACCESS PROGRAM (LEAP) to Provide Increased International Access to LEUKINE® (sargramostim)
  SocialTwist Tell-a-Friend  
   


Date: 25-03-2020 12:45PM
Source: Tanner Pharma Group
Category: General, Law & Justice, Healthcare & Biotechnology, Pharmaceutical
Location: Charlotte, N.C., United States

Business Wire India

Tanner Pharma Group today announced they are expanding their program by which the company provides access to LEUKINE® (sargramostim) in international markets. LEUKINE®, approved by the US FDA in 1991 and now manufactured by Partner Therapeutics, is a recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) that stimulates the immune system and has been used in leukemia patients to reduce the risk of infection.

On March 23, 2020, Partner Therapeutics announced that Leukine®is being assessed in the SARPAC trial (sargramostim in patients with acute hypoxic respiratory failure due to COVID-19 – EudraCT #2020-001254-22) at University Hospital Ghent, Belgium to treat patients with respiratory illness associated with COVID-19.

“The collaboration we have had with Tanner Pharma Group has given us a regulatory-compliant pathway to make LEUKINE available in international markets,” said Bob Mulroy, CEO of Partner Therapeutics. “The expansion of this partnership makes Tanner our designated program manager and creates a shared objective to more effectively provide access to more patients in need.”

If a patient is located in a country where Leukine is not available commercially and has a life-threatening illness whereby survival could potentially be prolonged in a clinically meaningful way, physicians may be able to have Leukine imported for their patients through named patient supply via the LEUKINE EMERGENCY ACCESS PROGRAM (LEAP) managed by Tanner.

“Leukine has been an important part of the treatment regimen for various diseases over the past thirty years; now, there is an even greater possible need as demonstrated by initiation of the clinical trial in Belgium,” said Banks Bourne, CEO of Tanner Pharma Group. “Tanner has been managing this access program for Leukine since May of 2018 and we are ready for this new, very important phase. Our team is incredibly honored to be trusted with the expansion of this collaboration, and we are mobilized to help patients around the world to make a positive impact.”

For more information about this program or to request access to LEUKINE®:

Telephone: +1 704 643 8989

Email: leukine@tannerpharma.com

About LEUKINE® (sargramostim)

Leukine® is a yeast-derived recombinant humanized granulocyte-macrophage colony stimulating factor (rhuGM-CSF) and the only FDA approved GM-CSF. GM-CSF is an important leukocyte growth factor known to play a key role in hematopoiesis, epithelial repair, and augmentation of innate host defense by effecting the growth and maturation of multiple cell lineages as well as the functional activities of these cells in antigen presentation and cell mediated immunity.

About Tanner Pharma Group

Tanner Pharma Group partners with biopharmaceutical companies to provide turn-key commercialization solutions to increase patient access to medicines around the world. With an unparalleled blend of local market knowledge, international supply chain expertise across more than 130 countries, and high regulatory compliance and quality standards, it provides tailored solutions to biopharmaceutical companies outside their core markets of focus. For more information, visit www.tannerpharma.com.



CONTACTS :

Christine Quern
CBQ Communications
cq@christinequern.com
617.650.8497

More Press Releases

Soul Is All That Matters: The All-New BMW R 18 Debuts in India

GLOBAL ART IN SHANGHAI TIME - The 2nd Shanghai International Artwork Trade Month Opening in October

Vidyashilp Community Trust Recognizes Government School Teachers for Their Contribution Towards Students and Society

Takeda Presents New Data Highlighting Scientific Advancements in Lung Cancer at ESMO Virtual Congress

Secure Code Warrior Named as a 2020 SINET 16 Innovator Award Winner

Owning a Home - Step Towards Atmanirbharta: Dr. Niranjan Hiranandani

Challenger Brand Niine Forays Into Hygiene and Personal Care With the Launch of Hand Wash and Hand Sanitizers

India’s Larsen & Toubro Defence Wins Infor Customer Excellence Awards 2020

Cotton Fab Creation Debuts First Clothing Line Gymmer

DHL Express Announces Annual Price Adjustments for 2021

Brii Biosciences Appoints Rogers Luo, Ankang Li To Leadership Positions

Innovation at the Core of IPLTech’s Operating Philosophy: Sid Das

PharmEasy Goes Live on PhonePe Switch Enabling Online Delivery of Medicines for Millions of Users

Limelight Enables Online Education With Multiple Customer Wins Across the World

Vifor Pharma Group Announces Successful Sale of OM Pharma

Paye Brahmangaon Mining and Stone Crushers Owners Association Have Demanded Exclusion of Four Villages From the Eco Sensitive Zone

Andersen Global Grows Caribbean Presence Through Collaboration in Jamaica

Immervision Introduces JOYCE, the First Humanoid Robot with Intelligent Vision Developed by the Computer Vision Community

Diligent Builds Momentum Behind Modern Leadership Initiative Providing Unprecedented Transparency into Board Recruitment to Advance Diversity

51Degrees Partners With Digital Element to Offer Market-leading Geolocation Technology

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
GST compensation: 21 states prefer borro...
Karnataka legislature set for stormy Mon...
Harsh Vardhan Lodha to move division ben...
18,855 people given Indian citizenship i...
India's COVID-19 tally crosses 54-lakh m...
12 parties gave vote of no confidence ag...
More...    
 
 Top Stories
Huawei working on a new phone with ... 
Bihar's 'Canal Man' Loungi gifted t... 
Four coronavirus vaccines in advanc... 
Owaisi attempting to get political ... 
70 members of Telangana BJP Yuva Mo... 
NHRC issues show cause notice to Ke... 
NCB SIT summons Jaya Shah, Shruti M... 
People will punish Opposition for m...